Dr Reddys Laboratories Ltd

Dr Reddy's Labs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dr Reddys Laboratories Ltd

₹ 6,661 -0.35%
13 Sep - close price
drreddys.com BSE: 500124 NSE: DRREDDY
About

Dr. Reddy's Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.

Key Points

Global Generics Segment (~83% of revenues in FY22)
Co. offers 400+ high-quality generic drugs, keeping costs reasonable by leveraging its integrated operations. The company benefits from its expertise in active ingredients, product development skills, a keen understanding of regulations and intellectual property rights & streamlined supply chain. [1]
Top revenue contributors of the segment are nervous system drugs (14%), gastrointestinal (13%) & anti-infective (10%) [2]
In FY22, co. filed 7 new ANDA’s with US FDA [3]

Website BSE NSE
  • Market Cap ₹ 1,11,147 Cr.
  • Current Price ₹ 6,661
  • High / Low ₹ 7,107 / 5,206
  • Stock P/E 27.0
  • Book Value ₹ 1,453
  • Dividend Yield 0.60 %
  • ROCE 25.2 %
  • ROE 19.2 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 27.4% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 23.9%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
3,434 3,823 3,480 3,669 3,631 4,880 3,898 4,554 5,437 4,839 4,103 5,105 5,841
2,872 3,075 2,866 2,999 3,051 3,078 3,222 3,493 3,210 3,210 3,447 3,726 3,888
Operating Profit 562 748 614 670 580 1,803 675 1,061 2,228 1,629 656 1,379 1,953
OPM % 16% 20% 18% 18% 16% 37% 17% 23% 41% 34% 16% 27% 33%
186 118 63 115 403 118 51 115 234 223 228 213 218
Interest 6 11 8 13 10 2 3 3 4 6 6 6 7
Depreciation 197 207 205 205 222 226 239 237 237 246 246 246 250
Profit before tax 544 649 464 567 752 1,693 485 937 2,220 1,601 632 1,339 1,914
Tax % 24% 31% 26% 26% 34% 34% 33% 28% 26% 25% 25% 23% 26%
413 449 341 420 500 1,116 325 672 1,639 1,193 475 1,035 1,417
EPS in Rs 24.85 26.98 20.50 25.22 30.01 67.06 19.49 40.38 98.43 71.51 28.49 62.03 84.95
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
8,370 9,728 10,011 10,292 9,720 9,359 10,626 11,850 13,349 14,405 16,962 19,484 19,888
6,383 6,950 7,608 8,219 7,899 7,990 8,290 8,967 10,212 11,803 12,724 13,557 14,271
Operating Profit 1,987 2,778 2,403 2,073 1,820 1,370 2,336 2,883 3,137 2,602 4,238 5,926 5,617
OPM % 24% 29% 24% 20% 19% 15% 22% 24% 24% 18% 25% 30% 28%
140 135 211 317 516 164 202 730 801 474 568 862 881
Interest 61 78 64 64 57 63 57 48 47 38 17 22 24
Depreciation 313 380 490 650 735 774 781 789 835 814 923 976 988
Profit before tax 1,753 2,454 2,060 1,677 1,544 697 1,701 2,776 3,056 2,224 3,866 5,791 5,486
Tax % 28% 21% 18% 18% 10% 19% 25% -6% 28% 27% 32% 25%
1,266 1,933 1,679 1,374 1,384 567 1,277 2,938 2,186 1,623 2,613 4,342 4,120
EPS in Rs 74.51 113.62 98.57 80.55 83.51 34.17 76.92 176.79 131.47 97.53 156.90 260.28 246.98
Dividend Payout % 20% 16% 20% 25% 24% 59% 26% 14% 19% 31% 26% 15%
Compounded Sales Growth
10 Years: 7%
5 Years: 13%
3 Years: 13%
TTM: 6%
Compounded Profit Growth
10 Years: 8%
5 Years: 27%
3 Years: 32%
TTM: 10%
Stock Price CAGR
10 Years: 8%
5 Years: 20%
3 Years: 10%
1 Year: 14%
Return on Equity
10 Years: 13%
5 Years: 15%
3 Years: 14%
Last Year: 19%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 85 85 85 85 83 83 83 83 83 83 83 83
Reserves 7,698 9,244 10,549 11,993 11,518 11,725 12,601 15,109 16,900 18,253 20,391 24,157
2,100 2,666 3,126 3,085 2,355 2,589 1,065 1,457 1,214 2,205 51 793
2,106 2,513 2,696 2,422 2,491 2,704 2,499 2,827 3,431 3,954 4,850 5,326
Total Liabilities 11,989 14,508 16,456 17,585 16,447 17,100 16,248 19,476 21,630 24,496 25,375 30,359
2,387 2,748 3,249 4,438 4,842 4,717 4,683 4,434 5,844 6,150 7,195 7,589
CWIP 423 576 488 616 540 675 400 412 901 1,200 924 1,211
Investments 2,379 2,806 3,862 5,076 3,102 3,636 3,934 5,486 4,649 4,937 7,440 7,321
6,800 8,377 8,856 7,455 7,963 8,072 7,231 9,145 10,235 12,208 9,815 14,239
Total Assets 11,989 14,508 16,456 17,585 16,447 17,100 16,248 19,476 21,630 24,496 25,375 30,359

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
289 906 1,786 2,747 1,016 1,539 2,762 1,839 3,514 1,339 5,053 3,450
-524 -874 -2,031 -1,919 1,430 -1,180 -546 -1,689 -1,454 -1,990 -3,403 -3,429
152 28 189 -693 -2,582 -304 -2,223 -224 -794 506 -2,697 68
Net Cash Flow -84 60 -56 135 -135 54 -8 -74 1,266 -146 -1,047 89

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 129 171 172 138 165 164 128 143 112 125 92 87
Inventory Days 217 233 223 234 256 258 242 224 250 242 219 291
Days Payable 109 123 93 99 110 147 124 109 118 121 127 148
Cash Conversion Cycle 237 281 302 273 311 274 246 257 243 247 184 230
Working Capital Days 131 181 179 156 182 180 143 148 128 144 95 144
ROCE % 20% 23% 16% 12% 11% 5% 12% 19% 15% 12% 19% 25%

Shareholding Pattern

Numbers in percentages

Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
26.72% 26.72% 26.72% 26.71% 26.71% 26.69% 26.69% 26.69% 26.66% 26.65% 26.65% 26.65%
27.76% 27.42% 25.16% 25.87% 26.26% 27.29% 27.25% 26.99% 28.19% 28.62% 29.13% 27.68%
21.40% 22.29% 24.78% 25.18% 24.69% 23.38% 23.05% 21.99% 21.04% 18.65% 18.31% 20.72%
23.83% 23.29% 23.07% 21.96% 22.06% 22.36% 22.78% 24.11% 23.93% 25.89% 25.73% 24.78%
0.29% 0.28% 0.28% 0.28% 0.27% 0.25% 0.22% 0.21% 0.18% 0.18% 0.17% 0.17%
No. of Shareholders 2,55,7202,42,3762,63,8032,55,3002,59,2712,46,7882,32,7152,46,7692,43,4452,57,7942,55,5002,67,694

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls